[Current status of immuno-gene therapy for hepatocellular carcinoma]

[Article in Chinese]

Affiliations

[Article in Chinese]

Shenglong Ye. Zhonghua Gan Zang Bing Za Zhi. 2002 Dec.

. 2002 Dec;10(6):407-8.

No abstract available

Similar articles

[Immunotherapy of hepatocellular carcinoma].
Geissler M, Mohr L, Blum HE. Geissler M, et al. Dtsch Med Wochenschr. 2001 Dec 21;126(51-52):1464-6. doi: 10.1055/s-2001-19215. Dtsch Med Wochenschr. 2001. PMID: 11753738 Review. German. No abstract available.
Immunology of hepatocellular carcinoma.
Paroli M, Perrone A, Bonavita MS, Barnaba V. Paroli M, et al. Ital J Gastroenterol. 1991 Nov;23(8):494-7. Ital J Gastroenterol. 1991. PMID: 1661196 Review.
Interleukin-12 gene therapy for hepatocellular carcinoma: a dream come true?
Tsai SL. Tsai SL. J Gastroenterol Hepatol. 2004 Oct;19(10):1097-100. doi: 10.1111/j.1440-1746.2004.03552.x. J Gastroenterol Hepatol. 2004. PMID: 15377285 No abstract available.
[Immunotherapy for hepatocellular carcinoma using dendritic cells].
Homma S, Toda G, Ohno T. Homma S, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:693-8. Nihon Rinsho. 2001. PMID: 11762039 Review. Japanese. No abstract available.
Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.
Zhang L, Zhang H, Liu W, Wang H, Jia J, Si X, Ren J. Zhang L, et al. Cell Immunol. 2005 Nov;238(1):61-6. doi: 10.1016/j.cellimm.2006.01.003. Epub 2006 Feb 10. Cell Immunol. 2005. PMID: 16472793